Fimasartan Ameliorates Nonalcoholic Fatty Liver Disease through PPAR delta Regulation in Hyperlipidemic and Hypertensive Conditions
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Yong-Jik | - |
dc.contributor.author | Jang, Yoo-Na | - |
dc.contributor.author | Han, Yoon-Mi | - |
dc.contributor.author | Kim, Hyun-Min | - |
dc.contributor.author | Jeong, Jong-Min | - |
dc.contributor.author | Seo, Hong Seog | - |
dc.date.accessioned | 2021-09-03T15:22:00Z | - |
dc.date.available | 2021-09-03T15:22:00Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2017 | - |
dc.identifier.issn | 1687-4757 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/86437 | - |
dc.description.abstract | To investigate the effects of fimasartan on nonalcoholic fatty liver disease in hyperlipidemic and hypertensive conditions, the levels of biomarkers related to fatty acid metabolism were determined in HepG2 and differentiated 3T3-L1 cells treated by high fatty acid and liver and visceral fat tissue samples of spontaneously hypertensive rats (SHRs) given high-fat diet. In HepG2 cells and liver tissues, fimasartan was shown to increase the protein levels of peroxisome proliferator-activated receptor delta (PPAR delta), phosphorylated 5' adenosine monophosphate-activated protein kinase (p-AMPK), phosphorylated acetyl-CoA carboxylase (p-ACC), malonyl-CoA decarboxylase (MCD), medium chain acyl-CoA dehydrogenase (MCAD), and peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1 alpha), and it led to a decrease in the protein levels of 11 beta-hydroxysteroid dehydrogenase 1 (11 beta-HSDH1), fatty acid synthase (FAS), and tumor necrosis factor-alpha (TNF-alpha). Fimasartan decreased lipid contents in HepG2 and differentiated 3T3-L1 cells and liver tissues. In addition, fimasartan increased the adiponectin level in visceral fat tissues. The antiadipogenic effects of fimasartan were offset by PPAR delta antagonist (GSK0660). Consequently, fimasartan ameliorates nonalcoholic fatty liver disease mainly through the activation of oxidative metabolism represented by PPAR delta-AMPK-PGC-1. pathway. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | HINDAWI LTD | - |
dc.subject | 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1 | - |
dc.subject | ACTIVATED PROTEIN-KINASE | - |
dc.subject | METABOLIC SYNDROME | - |
dc.subject | ADIPOSE-TISSUE | - |
dc.subject | AMPK | - |
dc.subject | STEATOHEPATITIS | - |
dc.subject | EXPRESSION | - |
dc.subject | EXERCISE | - |
dc.subject | OBESITY | - |
dc.subject | PHARMACOKINETICS | - |
dc.title | Fimasartan Ameliorates Nonalcoholic Fatty Liver Disease through PPAR delta Regulation in Hyperlipidemic and Hypertensive Conditions | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Yong-Jik | - |
dc.contributor.affiliatedAuthor | Seo, Hong Seog | - |
dc.identifier.doi | 10.1155/2017/8048720 | - |
dc.identifier.scopusid | 2-s2.0-85016587717 | - |
dc.identifier.wosid | 000398801400001 | - |
dc.identifier.bibliographicCitation | PPAR RESEARCH, v.2017 | - |
dc.relation.isPartOf | PPAR RESEARCH | - |
dc.citation.title | PPAR RESEARCH | - |
dc.citation.volume | 2017 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Research & Experimental Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, Research & Experimental | - |
dc.subject.keywordPlus | 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1 | - |
dc.subject.keywordPlus | ACTIVATED PROTEIN-KINASE | - |
dc.subject.keywordPlus | METABOLIC SYNDROME | - |
dc.subject.keywordPlus | ADIPOSE-TISSUE | - |
dc.subject.keywordPlus | AMPK | - |
dc.subject.keywordPlus | STEATOHEPATITIS | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | EXERCISE | - |
dc.subject.keywordPlus | OBESITY | - |
dc.subject.keywordPlus | PHARMACOKINETICS | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.